#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Infertility female Carcinoid syndrome Primary mediastinal large B-cell lymphoma Acute myeloid leukaemia refractory Transitional cell carcinoma B-cell lymphoma refractory Bronchopulmonary aspergillosis Follicular lymphoma stage III Uterine leiomyosarcoma Pneumonia Retinopathy proliferative Hypersensitivity pneumonitis Atopic keratoconjunctivitis Oesophageal squamous cell carcinoma stage II Hepatocellular carcinoma More trials…

    Learn about Rare Diseases

    Gastrointestinal stromal tumour – Treatment Pemphigoid Antithrombin III deficiency Antisynthetase syndrome – Basic Information Factor VIII deficiency – Treatment Hairy cell leukaemia recurrent – Diagnostics Pulmonary sarcoidosis MELAS syndrome – Basic Information Andersen-Tawil syndrome – Basic Information Gastrointestinal stromal tumour – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Messenger Rna Encoding Cas9 Donepezil Hydrochloride Mps-102 Elacestrant Rusfertide Quinidine Sulfate Prednisolone Sodium Phosphate Maridebart Cafraglutide Evolocumab Benztropine Mesylate Telmisartan Perflubutane Vesleteplirsen Pentixafor Human Fibrinogen Sulpiride Bi 1015550 Denosumab Brepocitinib Tosilate Azd5492 More therapies…

    Learn about Your Condition

    Anal squamous cell carcinoma Skin neoplasm excision Liver disorder Thyroid mass Hepatocellular carcinoma Alveolar rhabdomyosarcoma Endometriosis Alopecia areata Spinal muscular atrophy Stevens-Johnson syndrome Essential thrombocythaemia Dyspnoea Amnestic disorder Peptostreptococcus infection Cough More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Effects of Lysergide for Patients with Chronic Cluster Headache

    Recruiting

    2 1
    Investigated Diseases:
    • Cluster headache
    Investigated Drugs:
    • LYSERGIDE
    The Netherlands

  • Study on the Effects of DHEA and Melatonin on Sleep and Mood in Postmenopausal Women with Sleep Disorders

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Menopausal symptoms
    • Menopause
    • Sleep disorder
    Investigated Drugs:
    • Melatonin
    • Prasterone
    Poland

  • Study on Pembrolizumab for Patients with Early Triple-Negative Breast Cancer Responding Well to Initial Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Triple negative breast cancer
    Investigated Drugs:
    • Pembrolizumab
    Belgium France

  • Study on [18F]FAPI-74 for Better Cancer Imaging in Patients with Esophagogastric and Pancreatic Cancer

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Adenocarcinoma pancreas
    • Adenocarcinoma gastric
    • Oesophageal adenocarcinoma
    Investigated Drugs:
    • [Al[18F]F]Fapi-74
    Belgium

  • Study on the Effectiveness of Oxybutynin for Children with Overactive Neurogenic Bladder Due to Spina Bifida

    Recruiting

    3 1 1
    Investigated Diseases:
    • Spina bifida
    Investigated Drugs:
    • OXYBUTYNIN HYDROCHLORIDE
    France

  • Study on the Effectiveness of Cemiplimab, Carboplatin, and Paclitaxel for Unfit or Elderly Patients with Unresectable Stage III Non-Small Cell Lung Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage III
    Investigated Drugs:
    • Cemiplimab
    • Carboplatin
    • Paclitaxel
    France
Previous Page
1 … 248 249 250 251 252 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!